NCT06678659
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06678659
Title A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer (DAHLIA)
Acronym DAHLIA
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Recursion Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
SCRI Oncology Partners - PPDS WITHDRAWN Nashville Tennessee 37203 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
McGill University Health Centre (MUHC) - The Montreal RECRUITING Québec Canada H4A3J1 Canada Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 1X6 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field